If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnanda Developments Plc Regulatory News (ANA.PL)

Share Price Information for Ananda Developments Plc (ANA.PL)

Aquis Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.315
Bid: 0.28
Ask: 0.35
Change: 0.00 (0.00%)
Spread: 0.07 (25.00%)
Open: 0.315
High: 0.315
Low: 0.315
Prev. Close: 0.315
ANA.PL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

24 Aug 2023 14:28

RNS Number : 3807K
Ananda Developments PLC
24 August 2023
 

24 August 2023

 

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

 

Result of Annual General Meeting

 

Ananda Developments plc (AQSE: ANA) is pleased to announce that at the Annual General Meeting of the Company held earlier today all resolutions were duly passed by shareholders.

 

Proxy votes were received as follows:

 

Resolution

Votes for

%

Votes against

%

Votes total

Votes withheld

Resolution 1

278,538,686

99.99%

26,192

0.01%

278,564,878

6,976

Resolution 2

278,256,362

99.98%

46,725

0.02%

278,303,087

268,767

Resolution 3

278,276,792

99.99%

26,295

0.01%

278,303,087

268,767

Resolution 4

278,256,362

99.98%

46,725

0.02%

278,303,087

268,767

Resolution 5

278,256,362

99.98%

46,725

0.02%

278,303,087

268,767

Resolution 6

278,538,583

99.99%

26,295

0.01%

278,564,878

6,976

Resolution 7

278,276,792

99.99%

26,295

0.01%

278,303,087

268,767

Resolution 8

278,276,792

99.99%

26,295

0.01%

278,303,087

268,767

Resolution 9

278,291,237

99.99%

26,295

0.01%

278,317,532

254,322

Resolution 10

278,276,792

99.98%

48,748

0.02%

278,325,540

254,322

Resolution 11

278,256,362

99.98%

48,748

0.02%

278,305,110

274,752

 

-Ends-

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

ANANDA DEVELOPMENTS PLC

+44 (0)7463 686 497

ir@anandadevelopments.com

Chief Executive Officer

Melissa Sturgess

Finance Director

Jeremy Sturgess-Smith

SP ANGEL CORPORATE FINANCE LLP

+44 (0)20 3470 0470

Corporate Finance

Richard Morrison

Harry Davies-Ball

 

Corporate Broking

Abigail Wayne

Rob Rees

 

 

About Ananda Developments

 

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.

 

For more information, please visit: https://anandadevelopments.com/

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFLFFVTRISFIV
Date   Source Headline
2nd May 202412:00 pmRNSResponse to FSA-FSS Cannabidiol Safety Assessment
21st Mar 20247:00 amRNSEstablishment of Scientific Advisory Board
28th Feb 20247:00 amRNSEndometriosis Trial Drug Supply Agreement Signed
26th Feb 202412:00 pmRNSAnanda presenting at Master Investor Show
26th Feb 20247:00 amRNSQuarterly Trading Statement to 31 January 2024
6th Feb 20247:00 amRNSAppointment of Adviser
23rd Jan 20247:00 amRNSAppointment of Scientific Advisers
14th Dec 20237:00 amRNSAnanda Launches New Interactive Investor Hub
29th Nov 20232:39 pmRNSQuarterly Trading Statement to 31 October 2023
14th Nov 20237:00 amRNSDrug Supply Agreement Signed
8th Nov 20237:30 amRNSInvestor Presentation via Investor Meet Company
8th Nov 20237:00 amRNSTHC Oil Patent Application Filed
1st Nov 20237:00 amRNSMOU signed with Nottingham Trent University
24th Oct 20232:20 pmRNSInterim Results to 31 July 2023
6th Sep 20237:00 amRNSIssue of Convertible Loan Notes
31st Aug 20237:00 amRNSShareholder Update
25th Aug 202312:01 pmRNSResearch Roundup
24th Aug 20232:28 pmRNSResult of AGM
15th Aug 20237:00 amRNSNHS SCOTLAND TO FUND MRX1 ENDOMETRIOSIS TRIAL
31st Jul 20235:44 pmRNSCompletion of Audit & Notice of AGM
27th Jul 20237:00 amRNSFirst Cannabinoid Medicines Launched
13th Jul 202310:22 amRNSUnaudited Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.